Investor Presentaiton
8
00
Our leadership team encompasses decades of collective
experience and a common commitment to biosimilars
24
28
ROBERT WESSMAN
Chief Executive
Officer
HAFRUN
FRIDRIKSDOTTIR
Chief Operating
Officer
M
gsk
Alvogen
teva Actavis
Allergan
M
Actavis
20
A AZTIQ
Lotus
ADALVO
teva
20
JOSEPH E.
MCCLELLAN
Chief Scientific
Officer
Wyeth
Pfizer
20
17
JOEL MORALES
ANIL OKAY
Chief Financial
Officer
Chief Commercial
Officer
alvotech
20
TANYA ZHAROV
General Counsel &
Head of Legal
MERCK
KPMG
A AZTIQ ABDIIBRAHIM
deCODE genetics
PAR
PHARMACEUTICAL
SANOFI
RICHTER-HELM)
Alvogen
ADALVO
pwc
GIEDRIUS ZUNDA
Chief Technical
Officer
25
SANDRA CASACA
Chief Quality
Officer
20
PHILIP
CARAMANICA
Chief IP Counsel,
Deputy General
Counsel
Z-Biotech
Consulting
AMGEN abbvie
ll Bristol Myers Squibb
NORTHWAY®
BIOTECH
ATARA BIO
SANDOZA Novartis
Division
Synthon
CardinalHealth
20
30
MING LI
Chief Strategy
Officer
ROSE-MARIE
OHLSSON
Chief Information
Officer
ALPHARMA.
M
Actavis
Alvogen
A AZTIQ
●sobi
SEB
rare strength
© ALVOTECH. ALL RIGHTS RESERVEDView entire presentation